楊玉梅

【摘要】 目的 探討卡前列素氨丁三醇聯合垂體后葉素治療宮縮乏力性產后出血的療效。方法 72例
宮縮乏力性產后出血患者為觀察對象, 隨機分為對照組與觀察組, 每組36例。兩組均給予縮宮素, 在此基礎上, 對照組同時使用垂體后葉素治療, 觀察組同時使用卡前列素氨丁三醇聯合垂體后葉素治療。對比兩組的臨床療效。結果 觀察組總有效率為94.4%, 高于對照組的77.8%, 差異具有統計學意義(P<0.05)。觀察組產后出血量(158.5±75.5)ml明顯少于對照組的(252.5±100.5)ml、止血起效時間(14.6±8.6)min明顯短于對照組的(25.5±5.8)min, 差異均具有統計學意義(P<0.05)。結論 卡前列素氨丁三醇聯合垂體后葉素是宮縮乏力性產后出血的有效治療方案。
【關鍵詞】 卡前列素氨丁三醇;垂體后葉素;宮縮乏力性產后出血;臨床療效
DOI:10.14163/j.cnki.11-5547/r.2018.01.051
【Abstract】 Objective To discuss the efficacy of carboprost tromethamine combined with pituitrin in the treatment of uterine atony postpartum hemorrhage. Methods A total of 72 patients with uterine atony postpartum hemorrhage as observation subjects were randomly divided into control group and observation group, with
36 cases in each group. Both groups received oxytocin, and the control group was also treated with pituitrin. The observation group was treated with carboprost tromethamine combined with pituitrin. The clinical efficacy in two groups was compared. Results The observation group had higher total effective rate as 94.4% than 77.8% in the control group, and the difference was statistically significant (P<0.05). The observation group had obviously less postoperative bleeding volume as (158.5±75.5) ml than (252.5±100.5) ml in the control group, and obviously shorter hemostatic onset time as (14.6±8.6) min than (25.5±5.8) min in the control group. Their difference was statistically significant (P<0.05). Conclusion Combination of carboprost tromethamine and pituitrin is an effective regimen for the treatment of uterine atony postpartum hemorrhage.
【Key words】 Carboprost tromethamine; Pituitrin; Uterine atony postpartum hemorrhage; Clinical efficacy
產后出血是多因素造成的一種分娩期并發癥, 常見病因包括宮縮乏力、凝血功能障礙、產道裂傷、胎盤因素等。相關研究[1]指出產后出血具有發展迅速的特點, 少量出血可造成孕婦出現產褥感染、貧血和垂體前葉功能降低等, 大量出血可引發感染、失血性休克甚至死亡。據調查我國產后出血是孕產婦死亡的重要原因, 根據我國衛計委公布的統計數據報告中, 在造成孕產婦死亡的主要因素中, 產后出血占45.6% [2],
由此可見其對母嬰健康的威脅。因此加強預防、及時治療, 對提升產科工作質量具有重要意義。針對宮縮乏力性產后出血, 本文采取卡前列素氨丁三醇聯合垂體后葉素進行治療, 取得較好的療效, 現報告如下。
1 資料與方法
1. 1 一般資料 以2015年6月~2016年6月本院收治的72例確診為宮縮乏力性產后出血患者為觀察對象, 隨機將其分為觀察組與對照組, 每組36例。觀察組年齡24~38歲, 平均年齡(27.2±4.6)歲, 孕周35~40周, 平均孕周(38.2±……p>